The Long-Term Effect of Doxazosin, Finasteride, and Combination Therapy on the Clinical Progression of Benign Prostatic Hyperplasia

    December 2003 in “ The New England Journal of Medicine ”
    John J. McConnell, Claus G. Roehrborn, Oliver Bautista … Joseph A. Smith
    Studysummary Combination therapy of doxazosin and finasteride safely and effectively reduces benign prostatic hyperplasia progression risk.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on nejm.org →
    Discuss this study in the Community →

    Research cited in this study 4

    1. Urinary Retention in Patients with BPH Treated with Finasteride or Placebo Over 4 Years European Urology · 2000
    2. The Effect of Finasteride on the Risk of Acute Urinary Retention and the Need for Surgical Treatment Among Men with Benign Prostatic Hyperplasia The New England Journal of Medicine · 1998
    3. The Efficacy of Terazosin, Finasteride, or Both in Benign Prostatic Hyperplasia The New England Journal of Medicine · 1996
    4. The Effect of Finasteride in Men with Benign Prostatic Hyperplasia The New England Journal of Medicine · 1992

    Related research 1

    1. The Long-Term Effect of Doxazosin, Finasteride, and Combination Therapy on the Clinical Progression of Benign Prostatic Hyperplasia The New England Journal of Medicine · 2003